The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia:: Evidence from fixed- and random-effects meta-analyses

被引:52
作者
Glatt, SJ
Jönsson, EG
机构
[1] Univ Calif San Diego, Dept Psychiat, Inst Behav Genom, La Jolla, CA 92093 USA
[2] Karolinska Hosp, Dept Clin Neurosci, Psychiat Sect, S-10401 Stockholm, Sweden
关键词
association; dopamine D2 receptor; gene; meta-analysis; polymorphism;
D O I
10.1002/ajmg.b.30273
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Previously we derived independent estimates of the effect of the dopamine D2 receptor (DRD2) Ser311Cys polymorphism on risk for schizophrenia using fixed- and random-effects meta-analyses. Both analyses identified a significant association between the Cys allele and schizophrenia, but neither included all available data. Furthermore, genotype data were not evaluated in either analysis, thus precluding any determination of the mode of inheritance. The present study was conducted to resolve discrepancies between the existing meta-analyses, and provide more comprehensive and accurate estimates of the nature and magnitude of the influence of the Ser311Cys polymorphism on risk for schizophrenia. All discrepancies between the two sets of previously meta-analyzed studies were identified and resolved to the mutual satisfaction of the authors, and the final dataset was analyzed independently by fixed- and random-effects meta-analyses. A total of 27 samples, comprising 3,707 schizophrenia patients and 5,363 control subjects, were included in the analyses of allelic association, while smaller numbers of studies and subjects were included in each of the genotypic association analyses. A significant effect of the Cys allele was observed under both fixed-effects (odds ratio [OR] = 1.4; P = 0.002) and random-effects (OR = 1.4; P = 0.007) models. Cys/Ser heterozygotes were at elevated risk for schizophrenia when compared to Ser/Ser homozygotes (fixed- and random-effects OR = 1.4, p(s) >= 0.005), but Cys/Cys homozygotes were at no elevated risk relative to heterozygotes (OR = 1.0, p(s) >= 0.948). There was no evidence of heterogeneity, excessive influence of any single study, or publication bias in any of the analyses, suggesting that the effect of this DRD2 polymorphism on schizophrenia risk is reliable and uniform across populations, and our estimates of its magnitude are robust and accurate. (C) 2006 Wiley-Liss, Inc.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 41 条
[1]   Do we still believe in the dopamine hypothesis? New data bring new evidence [J].
Abi-Dargham, A .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 :S1-S5
[2]  
Arinami T, 1996, AM J MED GENET, V67, P133, DOI 10.1002/(SICI)1096-8628(19960409)67:2<133::AID-AJMG2>3.3.CO
[3]  
2-X
[4]   ASSOCIATION OF DOPAMINE D2 RECEPTOR MOLECULAR VARIANT WITH SCHIZOPHRENIA [J].
ARINAMI, T ;
ITOKAWA, M ;
ENGUCHI, H ;
TAGAYA, H ;
YANO, S ;
SHIMIZU, H ;
HAMAGUCHI, H ;
TORU, M .
LANCET, 1994, 343 (8899) :703-704
[5]  
ASHERSON P, 1994, LANCET, V343, P1045
[6]  
BECKER KG, 2002, GENETIC ASS DATABASE
[7]   PUBLICATION BIAS AND DISSEMINATION OF CLINICAL RESEARCH [J].
BEGG, CB ;
BERLIN, JA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (02) :107-115
[8]  
Chen HM, 1996, ENVIR SCI R, V51, P311
[9]   Problems of reporting genetic associations with complex outcomes [J].
Colhoun, HM ;
McKeigue, PM ;
Smith, GD .
LANCET, 2003, 361 (9360) :865-872
[10]  
Crawford F, 1996, AM J MED GENET, V67, P483, DOI 10.1002/(SICI)1096-8628(19960920)67:5<483::AID-AJMG8>3.0.CO